Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 35

1.

Serum dihydrotestosterone and testosterone concentrations in human immunodeficiency virus-infected men with and without weight loss.

Arver S, Sinha-Hikim I, Beall G, Guerrero M, Shen R, Bhasin S.

J Androl. 1999 Sep-Oct;20(5):611-8.

2.

The use of a transscrotal testosterone delivery system in the treatment of patients with weight loss related to human immunodeficiency virus infection.

Dobs AS, Cofrancesco J, Nolten WE, Danoff A, Anderson R, Hamilton CD, Feinberg J, Seekins D, Yangco B, Rhame F.

Am J Med. 1999 Aug;107(2):126-32.

PMID:
10460042
3.

Resistance exercise and supraphysiologic androgen therapy in eugonadal men with HIV-related weight loss: a randomized controlled trial.

Strawford A, Barbieri T, Van Loan M, Parks E, Catlin D, Barton N, Neese R, Christiansen M, King J, Hellerstein MK.

JAMA. 1999 Apr 14;281(14):1282-90.

PMID:
10208143
4.

Short-term progressive resistance training increases strength and lean body mass in adults infected with human immunodeficiency virus.

Roubenoff R, McDermott A, Weiss L, Suri J, Wood M, Bloch R, Gorbach S.

AIDS. 1999 Feb 4;13(2):231-9.

PMID:
10202829
5.

Effects of pharmacological doses of nandrolone decanoate and progressive resistance training in immunodeficient patients infected with human immunodeficiency virus.

Sattler FR, Jaque SV, Schroeder ET, Olson C, Dube MP, Martinez C, Briggs W, Horton R, Azen S.

J Clin Endocrinol Metab. 1999 Apr;84(4):1268-76.

PMID:
10199766
6.

Effects of nandrolone decanoate therapy in borderline hypogonadal men with HIV-associated weight loss.

Strawford A, Barbieri T, Neese R, Van Loan M, Christiansen M, Hoh R, Sathyan G, Skowronski R, King J, Hellerstein M.

J Acquir Immune Defic Syndr Hum Retrovirol. 1999 Feb 1;20(2):137-46.

PMID:
10048900
7.

Testosterone therapy for human immunodeficiency virus-positive men with and without hypogonadism.

Rabkin JG, Wagner GJ, Rabkin R.

J Clin Psychopharmacol. 1999 Feb;19(1):19-27.

PMID:
9934939
8.

Effects of testosterone replacement with a nongenital, transdermal system, Androderm, in human immunodeficiency virus-infected men with low testosterone levels.

Bhasin S, Storer TW, Asbel-Sethi N, Kilbourne A, Hays R, Sinha-Hikim I, Shen R, Arver S, Beall G.

J Clin Endocrinol Metab. 1998 Sep;83(9):3155-62.

PMID:
9745419
9.

Effects of androgen administration in men with the AIDS wasting syndrome. A randomized, double-blind, placebo-controlled trial.

Grinspoon S, Corcoran C, Askari H, Schoenfeld D, Wolf L, Burrows B, Walsh M, Hayden D, Parlman K, Anderson E, Basgoz N, Klibanski A.

Ann Intern Med. 1998 Jul 1;129(1):18-26.

PMID:
9652995
10.

The use of a sensitive equilibrium dialysis method for the measurement of free testosterone levels in healthy, cycling women and in human immunodeficiency virus-infected women.

Sinha-Hikim I, Arver S, Beall G, Shen R, Guerrero M, Sattler F, Shikuma C, Nelson JC, Landgren BM, Mazer NA, Bhasin S.

J Clin Endocrinol Metab. 1998 Apr;83(4):1312-8. Erratum in: J Clin Endocrinol Metab 1998 Aug;83(8):2959.

PMID:
9543161
11.

The effect of exercise training on aerobic fitness, immune indices, and quality of life in HIV+ patients.

Stringer WW, Berezovskaya M, O'Brien WA, Beck CK, Casaburi R.

Med Sci Sports Exerc. 1998 Jan;30(1):11-6.

PMID:
9475639
12.

A trial of testosterone therapy for HIV-associated weight loss.

Coodley GO, Coodley MK.

AIDS. 1997 Sep;11(11):1347-52.

PMID:
9302444
13.

Testosterone replacement increases fat-free mass and muscle size in hypogonadal men.

Bhasin S, Storer TW, Berman N, Yarasheski KE, Clevenger B, Phillips J, Lee WP, Bunnell TJ, Casaburi R.

J Clin Endocrinol Metab. 1997 Feb;82(2):407-13.

PMID:
9024227
14.

Recombinant human growth hormone in patients with HIV-associated wasting. A randomized, placebo-controlled trial. Serostim Study Group.

Schambelan M, Mulligan K, Grunfeld C, Daar ES, LaMarca A, Kotler DP, Wang J, Bozzette SA, Breitmeyer JB.

Ann Intern Med. 1996 Dec 1;125(11):873-82.

PMID:
8967667
15.

Recombinant human growth hormone, insulin-like growth factor 1, and combination therapy in AIDS-associated wasting. A randomized, double-blind, placebo-controlled trial.

Waters D, Danska J, Hardy K, Koster F, Qualls C, Nickell D, Nightingale S, Gesundheit N, Watson D, Schade D.

Ann Intern Med. 1996 Dec 1;125(11):865-72.

PMID:
8967666
16.

Increase in bone density and lean body mass during testosterone administration in men with acquired hypogonadism.

Katznelson L, Finkelstein JS, Schoenfeld DA, Rosenthal DI, Anderson EJ, Klibanski A.

J Clin Endocrinol Metab. 1996 Dec;81(12):4358-65.

PMID:
8954042
17.

Serum hormones in men with human immunodeficiency virus-associated wasting.

Dobs AS, Few WL 3rd, Blackman MR, Harman SM, Hoover DR, Graham NM.

J Clin Endocrinol Metab. 1996 Nov;81(11):4108-12.

PMID:
8923868
18.

Loss of lean body and muscle mass correlates with androgen levels in hypogonadal men with acquired immunodeficiency syndrome and wasting.

Grinspoon S, Corcoran C, Lee K, Burrows B, Hubbard J, Katznelson L, Walsh M, Guccione A, Cannan J, Heller H, Basgoz N, Klibanski A.

J Clin Endocrinol Metab. 1996 Nov;81(11):4051-8.

PMID:
8923860
19.
20.

Supplemental Content

Support Center